KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind ®, a leading mental health care company, is launching on August 10, 2019 Genomind Professional PGx Express™, a new, more focused report and set of ...

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind ®, the leading mental health company bringing precision medicine into mainstream mental health treatment, and Jewel-Osco have expanded their partnership ...

The company is seeking to raise additional funding. Genomind, area Acme parent partner to up awareness of genetic tes Montco firm introduces its latest genetic mental health tool Montco firm ...

(BPT) - If you or a family member have sought care from a mental health professional, or are considering seeking help for depression, anxiety, ADHD or other conditions, you want the best treatment ...

GLEN ALLEN, Va., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the ...

King of Prussia-based mental health company Genomind recently expanded its partnership with Acme markets, making its genetic testing service available to patients in all 37 Acme pharmacies across ...

KING OF PRUSSIA, Pa. and ATLANTA, Dec. 9, 2019 /PRNewswire/ -- Genomind®, the leading mental health company, and Sharecare, the digital health company that helps people manage all their health in one ...

Paolo Russo demonstrates how visitors can use the Aurasma app to connect to the artwork, digitally. Mental health platform NeuroFlow has been making moves this year. Now, NeuroFlow has joined forces ...

Partnership has successfully completed analytical validation of a cheek swab collection solution for testing and identifying patients with the genotypes important for AD04 development GLEN ALLEN, Va., ...

GLEN ALLEN, Va., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for ...